Literature DB >> 33409666

Cardiac 1H MR spectroscopy: development of the past five decades and future perspectives.

Ashish Gupta1, Brian Houston2.   

Abstract

Continued advances in laboratory medicine are required to realize the potential of individualized medicine to impact common cardiovascular diseases. Magnetic resonance imaging (MRI) and spectroscopy (MRS) techniques have advanced over recent years and offer unique, powerful insights into cardiac anatomic and metabolic changes, respectively, occurring in both nascent and advanced heart disease. Although numerous MRI-based in vivo diagnostics are already used in routine clinical practice and more are anticipated, MRS has been less incorporated into routine clinical practice. Given the ability of 1H MRS to identify and quantify specific molecules with high sensitivity and specificity, its potential utility should be successfully transition from "bench-to-bedside" is tantalizing. The present review will highlight the development of 1H MRS techniques for cardiac applications, observations in seminal studies with 1H MRS, and the prospects and challenges for widespread application in patients with cardiovascular disease.

Entities:  

Keywords:  Cardiac 1H MRS; Creatine; Ex vivo; In vivo; Lipid; Triglyceride

Mesh:

Year:  2021        PMID: 33409666     DOI: 10.1007/s10741-020-10059-5

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  40 in total

1.  Demonstration of increased myocardial lipid with postischemic dysfunction ("myocardial stunning") by proton nuclear magnetic resonance spectroscopy.

Authors:  R C Reeves; W T Evanochko; R C Canby; J B McMillin; G M Pohost
Journal:  J Am Coll Cardiol       Date:  1989-03-01       Impact factor: 24.094

2.  Proton magnetic resonance (PMR) studies of water in dimethyl sulfoxide perfused rat myocardium.

Authors:  T I Malinin; R L Nunnally
Journal:  Physiol Chem Phys       Date:  1976

3.  Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium.

Authors:  P A Bottomley; R G Weiss
Journal:  Lancet       Date:  1998-03-07       Impact factor: 79.321

4.  Proton nuclear magnetic resonance relaxation times in severe myocardial ischemia.

Authors:  R C Canby; R C Reeves; W T Evanochko; G A Elgavish; G M Pohost
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

5.  Prolongation of proton spin lattice relaxation times in regionally ischemic tissue from dog hearts.

Authors:  E S Williams; J I Kaplan; F Thatcher; G Zimmerman; S B Knoebel
Journal:  J Nucl Med       Date:  1980-05       Impact factor: 10.057

6.  1H and 13C NMR spectroscopic study of rat organs.

Authors:  K Yoshikawa; A Ohsaka
Journal:  Physiol Chem Phys       Date:  1980

7.  Lactate accumulation in ischemic- and anoxic-isolated rat hearts assessed by H-1 spectroscopy.

Authors:  T L Richards; F Terrier; R E Sievers; M J Lipton; M E Moseley; C B Higgins
Journal:  Invest Radiol       Date:  1987-08       Impact factor: 6.016

8.  Transmural distribution of myocardial edema by NMR relaxometry following myocardial ischemia and reperfusion.

Authors:  B L Karolle; R E Carlson; A M Aisen; A J Buda
Journal:  Am Heart J       Date:  1991-09       Impact factor: 4.749

9.  Proton relaxation enhancement in tissue due to ingested manganese chloride: time course and dose response in the rat.

Authors:  A C Mamourian; K R Burnett; E J Goldstein; G L Wolf; H Y Kressel; S Baum
Journal:  Physiol Chem Phys Med NMR       Date:  1984

10.  Nuclear magnetic resonance spectroscopy of rat ventricles following supravalvar aortic banding. A model of left ventricular hypertrophy.

Authors:  R Fried; L M Boxt; R H Miller; M Marx; M Aronovitz; L M Reid; D F Adams
Journal:  Invest Radiol       Date:  1986-08       Impact factor: 6.016

View more
  1 in total

Review 1.  Low Tissue Creatine: A Therapeutic Target in Clinical Nutrition.

Authors:  Sergej M Ostojic
Journal:  Nutrients       Date:  2022-03-15       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.